Considerations for a Successful Biosimilars Program 2016 is a webinar that covers topics such as:
- Current regulatory guidelines and considerations for bringing biosimilars to market
- BPCI Act of 2009
- Integration of biosimilarity and comparability into developing biosimilars
- Strategies for developing and manufacturing biosimilars
- CMC regulatory challenges and considerations
- Identifying challenges encountered with extrapolations and Interchangeability
- Nonclinical and clinical challenges
Considerations for a Successful Biosimilars Program 2016 is intended for attendees from:
- Functional Area Managers
- Senior Scientists and above
- Directors
- Vice Presidents
- Quality/Regulatory Managers
- Project Managers
- Investors
- Principle Investigators
